5th Annual Pharmaceutical Regulatory Affairs Asia 2012

Asia presents huge commercial opportunity to the global pharma market. However this potential can only be realized with successful regulatory approval.

The 5th Annual Pharmaceutical Regulatory Affairs Asia 2012 covers topics such as:

• Multiple influences on regulatory approval for clinical trials and marketing authorization
• Strategies for lifecycle management including IP, regulatory and drug delivery approaches
• Threats facing intellectual property and products in emerging markets and strategies to protect your IP, products and data exclusivity
• Strategies to optimize communication with health authorities

The 5th Annual Pharmaceutical Regulatory Affairs Asia 2012 brings together attendees from Pharmaceutical / Generics / Biopharmaceuticals companies, Regulatory authorities (government) & Ministry of Health, Clinical Research Organizations / Consultancies and Medical Devices / Diagnostics Companies.